ESPE Yearbook of Paediatric Endocrinology

ESPE Yearbook of Paediatric Endocrinology

ISSN 1662-4009 (online)

Published by BioScientifica
Previous issue | Volume 20 | ESPEYB20 | Next issue

Yearbook of Paediatric Endocrinology 2023

10. Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism

New Drugs for Children with T2DM

Previous section
New Data on the Epidemiology of T2D in Children
Table of contents
Next section
Metabolic Syndrome

ey0020.10-4 | New Drugs for Children with T2DM

10.4. Once-weekly dulaglutide for the treatment of youths with type 2 diabetes

ey0020.10-5 | New Drugs for Children with T2DM

10.5. Once-weekly exenatide in youth with type 2 diabetes

ey0020.10-6 | New Drugs for Children with T2DM

10.6. Deterioration of glycemic control in youth-onset type 2 diabetes: What are the early and late predictors?

ey0020.10-7 | New Drugs for Children with T2DM

10.7. Maternal diabetes in youth-onset type 2 diabetes is associated with progressive dysglycemia and risk of complications

ey0020.10-8 | New Drugs for Children with T2DM

10.8. Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial

Published by BioScientifica

ESPE Yearbook of Paediatric Endocrinology
ISSN 1662-4009 (Online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more